Statement of Federal Trade Commission Chairman Jon Leibowitz on Ending Pay-for-Delay Drug Settlements, Praises Inclusion in Presidents Health Care Proposal

Posted byIR Press Leave a comment on Statement of Federal Trade Commission Chairman Jon Leibowitz on Ending Pay-for-Delay Drug Settlements, Praises Inclusion in Presidents Health Care Proposal

“When drug companies agree not to compete, consumers lose,” said Federal Trade Commission Chairman Jon Leibowitz. “Ending pay-for-delay settlements will help control drug costs. We’re delighted about the President’s resolute support for this bipartisan initiative.”

(JDL stmt)

Related posts:

  1. Statement by FTC Chairman Jon Leibowitz Regarding Today’s District Court Decision Denying a Motion to Dismiss the Commission’s Pay-For-Delay Case Against Cephalon Inc.
  2. FTC Chairman, Members of Congress Call for Legislation to End Sweetheart Pay-for-Delay Deals That Keep Generic Drugs Off the Market
  3. FTC Chairman Leibowitz: Eliminating Pay-for-Delay Pharmaceutical Settlements Would Save Consumers $3.5 Billion Annually
  4. FTC Testifies in Support of Bill Banning Pay-for-Delay Settlements Between Brand and Generic Drug Companies

Leave a comment

Your email address will not be published. Required fields are marked *